An experimental study of the effect of aprotinin on intestinal adhesion formation

American Journal of Surgery

Volumn 175, Issue 2, 1998, Pages 137-141

  Yusuf, Özoǧul ^a   Baykal, Ataç ^b   Onat, Demirali ^b   Renda, Nurten ^b   Sayek, Iskender ^b,c  

^a Tokat State Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; HYDROXYPROLINE; METHYLPREDNISOLONE;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG SCREENING; FIBRINOLYSIS; ILEUM; INTESTINE ISCHEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADHESIONS; ANIMALS; APROTININ; FIBRINOLYSIS; HEMOSTATICS; HYDROXYPROLINE; INTESTINAL DISEASES; INTESTINE, SMALL; RATS; RATS, WISTAR;

EID: 0032006155     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00273-0     Document Type: Article

References (33)

1. 1. Menzies D, Ellis H. Intestinal obstruction from adhesions - how big is the problem? Ann R Coll Surg Engl. 1990;72:60-63.
2. 2. Hershlag A, Diamond MP, DeCherney AH. Adhesiolysis. Clin Obstet Gynecol. 1991;34:395.
3. 3. Fayez JA. An assessment of the role of operative laparoscopy in tuboplasty. Fertil Steril. 1983;39:476.
4. 4. Milligan DW, Raftery AT. Observations on the pathogenesis of peritoneal adhesions: a light and electron microscopical study. Br J Surg. 1974;61:274.
5. 5. Whawell SA, Wang Y, Fleming KA, et al. Localization of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridization. J Pathol. 1993;169:67.
6. 6. Young HL, Wheeler MH, Morse D. The effect of intravenous aprotinin (Trasylol) on intraperitoneal adhesion formation in the rat. Br J Surg. 1981;68:59-60.
7. 7. Raftery AT. Noxythiolin (Noxyflex), aprotinin (Trasylol) and peritoneal adhesion formation: an experimental study in the rat. Br J Surg. 1979:66:654-656.
8. 8. Gazzaniga AB, James JM, Shobe JB, Oppenheim EB. Prevention of peritoneal adhesions in the rat. Arch Surg. 1975;110:429-432.
9. 9. Evans DM, McAree K, Guyton DP, et al. Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions. Am J Surg. 1993;165: 229-232.
10. 10. Lowry, OH. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265.
11. 11. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Ann Chem. 1963;35:1961.
12. 12. Buckman RF, Buckman PD, Hufnegel HV, Gervin AS. A physiologic basis for adhesion free healing of deperitonealized surfaces. J Surg Res. 1976;21:67.
13. 13. Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem. 1952;40:346.
14. 14. Replogle RL, Johnson R, Gross RE. Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy. Ann Surg. 1965;10:580.
15. 15. Replogle RL, Johnson R, Gross RE. Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy: experimental and clinical studies. Ann Surg. 1966;167:500-510.
16. 16. Meisler N, Shull S, Xie R, et al. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes. J Cel Biochem. 1995;59:376-388.
17. 17. Nishimura K, Nakamura RM, Diseraga GS. Biochemical evaluation of postsurgical wound repair: prevention of intraperitoneal adhesion formation with ibuprofen. J Surg Res. 1983;34:219.
18. 18. Cronin K, Jackson DS, Dunphy JE. Changing burst strength and collagen content of the healing colon. Surg Gynecol Obstet. 1968;126:747.
19. 19. Mooney R. Prevention of peritoneal adhesions with aprotinin (Trasylol). J Int Med Res. 1976;4:360-363.
20. 20. Perovic S, Maksimovic LJ, Djaja M, Tonic LT. Prophylaxis of adhesions with Trasylol in cases of perforated appendicitis in children. J Int Med Res. 1978;6:89-93.
21. 21. Vipond MN, Whawell SA, Thompson JN, Dudley HAF, Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet. 1990;335:1120-1122.
22. 22. Scott-Coombes D, Whawell S, Vipond MN, Thompson J. Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg. 1995;82:414-417.
23. 23. Kallis P, Tooze JA, Talbot S, et al. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial. Eur J Cardiothorac Surg. 1994;8:315.
24. 24. Liu B, Tengborn L, Larson G, et al. Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operations. Ann Thorac Surg. 1995;59:1534.
25. 25. Mastroroberto P, Chello M, Zofrea S, Marchese AR. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss. Eur J Cardiothorac Surg. 1995;9:143.
26. 26. Scudamore CH, Randall TE, Jewesson PJ, et al. Aprotinin reduces the need for blood products during liver transplantation. Am J Surg. 1995;169:546.
27. 27. Laiho M, Saksela O, Keski-Oja J. Transforming growth factorbeta induction and type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem. 1987;262:17467-17474.
28. 28. Yee JA, Yan L, Dominguez JC, et al. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. J Cell Phy. 1993;157:34.
29. 29. Ciacci C, Lind SE, Podolsky DK. Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology. 1993;105:93.
30. 30. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscleros Thrombos. 1991;11:1223-1230.
31. 31. Bernstein EF, Harisiadis L, Salomon G, et al. Transforming growth factor-beta improves healing of radiation-impaired wounds. J Invest Dermat. 1991;97:430-434.
32. 32. Stetler-Stevenson WG, Brown PD, Onisto M, et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem. 1990;265: 13933-13938.
33. 33. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and collagen formation in vitro. Proc Natl Acad Sci USA. 1986;83:4167-4171.